Universidad de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (32)

2020

  1. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?

    Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 835-843

2019

  1. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation: Mechanistic insights and clinical implications

    Hypertension, Vol. 73, Núm. 3, pp. 602-611

  2. Circulating long noncoding RNA LIPCAR Predicts heart failure outcomes in patients without chronic kidney disease

    Hypertension, Vol. 73, Núm. 4, pp. 820-828

  3. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1398-1410

2018

  1. Myocardial remodeling in hypertension toward a new view of hypertensive heart disease

    Hypertension, Vol. 72, Núm. 3, pp. 549-558

2017

  1. Hypertensive Heart Disease

    Encyclopedia of Cardiovascular Research and Medicine (Elsevier), pp. 517-526

  2. Papel del colágeno miocárdico en la estenosis aórtica grave con fracción de eyección conservada y síntomas de insuficiencia cardiaca

    Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 832-840

  3. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

    Journal of Hypertension, Vol. 35, Núm. 4, pp. 853-861

2016

  1. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: Potential role of altered collagen metabolism

    Journal of Hypertension, Vol. 34, Núm. 1, pp. 130-138

  2. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure

    Journal of the American College of Cardiology, Vol. 67, Núm. 3, pp. 251-260

2010

  1. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction

    Hypertension, Vol. 55, Núm. 6, pp. 1418-1424

2009

  1. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: Potential diagnostic implications

    Journal of Hypertension, Vol. 27, Núm. 2, pp. 418-424

2007

  1. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure

    Journal of Hypertension, Vol. 25, Núm. 10, pp. 2148-2157

  2. Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure

    Journal of the American College of Cardiology, Vol. 50, Núm. 9, pp. 859-867

  3. The role of myocardial collagen network in hypertensive heart disease

    Current Hypertension Reviews, Vol. 3, Núm. 1, pp. 1-7

  4. Upregulation of myocardial Annexin A5 in hypertensive heart disease: Association with systolic dysfunction

    European Heart Journal, Vol. 28, Núm. 22, pp. 2785-2791

2006

  1. Alteraciones del metabolismo del colágeno fibrilar en la cardiopatía hipertensiva. Situación actual y perspectivas

    Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1047-1057

  2. Alterations in the Pattern of Collagen Deposition May Contribute to the Deterioration of Systolic Function in Hypertensive Patients With Heart Failure

    Journal of the American College of Cardiology, Vol. 48, Núm. 1, pp. 89-96

  3. Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease

    Cardiovascular Research, Vol. 69, Núm. 4, pp. 899-907

  4. Apoptosis in hypertensive heart disease: A clinical approach

    Current Opinion in Cardiology, Vol. 21, Núm. 4, pp. 288-294